| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/04/2006 | US7071319 Recombinant antibodies, and compositions and methods for making and using the same |
| 07/04/2006 | US7071317 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 07/04/2006 | US7071316 Human Akt-3 |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071311 Antibodies having specificity for 2′-C-allyl nucleic acids |
| 07/04/2006 | US7071310 Antibody against the human toll- like receptor 2 (tlr2) and uses thereof |
| 07/04/2006 | US7071309 Determination metastasis using protein |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071301 Supplying vector; amino acid sequence for binding virus; modifying sequence for binding second virus; genetic engineered polypeptide |
| 07/04/2006 | US7071296 vaccines against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/04/2006 | US7071293 Protein; biological antigrowth agent; bactericides |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7071004 Isolated nucleic acids; uisng gene expression as indicator of cancer; insertion gene in transgenic animals |
| 07/04/2006 | US7070995 CE7-specific redirected immune cells |
| 07/04/2006 | US7070991 Cells expressing a CD4-IgG2 chimeric heterotetramer |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070975 Comprises disintegrin enzymatic polypeptide for use in the identification of modulators for treatment of bone, vision and respiratory system disorders; enzyme inhibitors |
| 07/04/2006 | US7070974 Polymerase chain reactions; cloning; screening Dna libraries; fusion protein in Escherichia; forming antibodies; isolated nucleic acid |
| 07/04/2006 | US7070972 Isolated polynucleotide; catalyst; transformation lymphocytes; antibodies; detecting therapy agents |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070959 Prevent blood leakage or vacular system permeability; isolated nucleic acid; fusion protein containing endothelial growth factor and immunoglobulins |
| 07/04/2006 | US7070945 Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment |
| 07/04/2006 | US7070939 Methods for detecting vasculopathies and tumors |
| 07/04/2006 | US7070793 Antigen protein and nucleic acid coding for said protein |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 07/04/2006 | US7070787 Relates to immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates and method of inducing anti-HIV antibodies using such immunogen |
| 07/04/2006 | US7070786 RSV proteins, antibodies, compositions, methods and uses |
| 07/04/2006 | US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 07/04/2006 | US7070778 treating breast concer by administering a monoclonal antibody with an oligo- beta -(1,3)-glucan and a carrier |
| 07/04/2006 | US7070777 Method for inhibiting inflammation with an antibody that binds the 5C8 protein |
| 07/04/2006 | US7070776 inhibiting an immune response by reacting B7 positive cells with an antibody which binds with B7 antigen having a specific amino acid sequence |
| 07/04/2006 | US7070775 Recombinant A2-specific TNFα specific antibodies |
| 07/04/2006 | CA2205359C Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x->=41) and tau |
| 06/29/2006 | WO2006069403A2 Methods for producing soluble multi-membrane-spanning proteins |
| 06/29/2006 | WO2006069202A2 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 06/29/2006 | WO2006068975A2 Binding proteins specific for human matriptase |
| 06/29/2006 | WO2006068953A2 Antibodies directed to angiopoietin-2 and uses thereof |
| 06/29/2006 | WO2006068867A1 Combination therapy for b cell disorders |
| 06/29/2006 | WO2006068640A1 Protein phosphorylation in egfr-signaling pathways |
| 06/29/2006 | WO2006068625A1 Novel snake toxin |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006067506A2 Hiv resistance genes |
| 06/29/2006 | WO2006067465A2 Cancer treatment |
| 06/29/2006 | WO2006067402A2 Agents inibiting the cathelin-like protein cap18/ll-37 |
| 06/29/2006 | WO2006067210A1 Bcma polypeptides and uses thereof |
| 06/29/2006 | WO2006067134A1 Combination treatment for multiple sclerosis |
| 06/29/2006 | WO2006067094A1 Method for isolating neural cells using tenascin-r compounds |
| 06/29/2006 | WO2006066878A1 Prevention of thrombus formation and/or stabilization |
| 06/29/2006 | WO2006066568A2 Antibody |
| 06/29/2006 | WO2006036834A3 MODIFIED Fc MOLECULES |
| 06/29/2006 | WO2006023420A3 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 06/29/2006 | WO2006015079A3 Erm family binding agents and their use in diagnosis and treatment of proliferative conditions |
| 06/29/2006 | WO2006002377A3 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 06/29/2006 | WO2005124352A3 Method for determining aggrecanase activities |
| 06/29/2006 | WO2005120437A3 Method for treating lupus |
| 06/29/2006 | WO2005117848A3 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 06/29/2006 | WO2005110338A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 06/29/2006 | WO2005042581A8 Modified anti-cd52 antibody |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2004044125A3 Vesicle-associated proteins |
| 06/29/2006 | WO2003106644A3 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 06/29/2006 | WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 06/29/2006 | US20060143725 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 06/29/2006 | US20060142550 Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation |
| 06/29/2006 | US20060142549 Method of purifying protein |
| 06/29/2006 | US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060141597 Valency platform molecules comprising aminooxy groups |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141577 Selection of host cells expressing protein at high levels |
| 06/29/2006 | US20060141576 Variants of corticotropin releasing hormone receptor type 1 and uses thereof |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141548 Immunoassays for everolimus |
| 06/29/2006 | US20060141547 Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
| 06/29/2006 | US20060141545 Cancer treatment kits using antibodies to aminophospholipids |
| 06/29/2006 | US20060141540 Direct selection of cells by secretion product |
| 06/29/2006 | US20060141535 Hyaluronan receptor for endocytosis |
| 06/29/2006 | US20060141531 Self-assembled relay probe; peptide tag bound to the target material; a fluorescent conjugate, a fluorochrome and a tag binding group; conjugate selectively associates with the first tag; a second peptide tag bound to the target material with a second fluorochrome having a longer wavelength |
| 06/29/2006 | US20060141524 Novel kinases and uses thereof |
| 06/29/2006 | US20060141522 Screening methods for identifying agonists and antagonists of hereulin -like factor (HLF) activity; diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation |
| 06/29/2006 | US20060141517 Protein having PDZ domain sequence |
| 06/29/2006 | US20060141482 Method and multicomponent conjugates for treating cancer |
| 06/29/2006 | US20060141479 Diagnosis, psoriasis, rheumatoid arthritis, emphysema, asthma, diabetes, autoimmune thyroiditis, inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, different types of dermatitis including allergic dermatitis, contact dermatitis, actinic keratosis, wound healing, cancer |
| 06/29/2006 | US20060141468 Novel notch-like polypeptides |
| 06/29/2006 | US20060141456 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141451 Guinea pig proteinase-activated receptor 4 and its activating peptide |
| 06/29/2006 | US20060140980 Immunization of non-human mammals against streptococcus equi |
| 06/29/2006 | US20060140979 Antigenic polypeptides |
| 06/29/2006 | US20060140977 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 06/29/2006 | US20060140964 Human igm antibody lysing activated lymphocytes under mediation by homologous complement |
| 06/29/2006 | US20060140963 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 06/29/2006 | US20060140962 Combination treatment of pancreatic cancer |
| 06/29/2006 | US20060140961 Compositions and methods for the diagnosis and treatment of tumor |
| 06/29/2006 | US20060140959 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof |
| 06/29/2006 | US20060140958 Tumor antigen (TAG); labeled nucleotide sequence; gives rise to antigenic peptides which bind to major histocompatibility complex and recognized by cytotoxic lymphocytes; diagnosis and treatment of cancer |
| 06/29/2006 | US20060140957 Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis |
| 06/29/2006 | US20060140955 Specific isotype antibodies of secretion-excretion anti-antigens of leishmania sp of promastigote or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, and as immunotherapeutic effectors |